MET · NYSE
MetLife (MET) Stock Price & Fundamentals
MetLife (MET) closed at $416.72 on Oct 9, 2026, up 0.75% from the previous close of $413.61.
Share price, past year
1Y +10.89%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $416.72 |
| Sep 30, 2026 | $397.32 |
| Aug 31, 2026 | $398.82 |
| Jul 31, 2026 | $398.61 |
| Jun 30, 2026 | $407.33 |
| May 29, 2026 | $427.27 |
| Apr 30, 2026 | $449.21 |
| Mar 31, 2026 | $437.08 |
| Feb 27, 2026 | $428.18 |
| Jan 30, 2026 | $407.73 |
| Dec 31, 2025 | $388.11 |
| Nov 28, 2025 | $396.99 |
| Oct 31, 2025 | $391.09 |
Key statistics
- Market cap
- $265.76B
- P/E (TTM)
- 79.7
- EPS (TTM)
- $5.23
- Revenue (TTM)
- $79.40B
- Net income (TTM)
- $3.63B
- Shares outstanding
- 637.8M
- Dividend yield
- —
- 52-week range
- $371.82 – $450.90
MetLife's market cap is $265.76B, based on a share price of $416.72 and 637.8M shares outstanding as of Jun 30, 2026.
Financials
MetLife reported revenue of $77.08B for fiscal 2025, up 8.59% from fiscal 2024.
MetLife earned net income of $3.38B in fiscal 2025, a net margin of 4.4%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $77.08B | +8.6% | $3.38B | 4.4% | $4.71 | — |
| FY2024ended Dec 31, 2024 | $70.99B | +6.1% | $4.43B | 6.2% | $5.94 | — |
| FY2023ended Dec 31, 2023 | $66.91B | −2.7% | $1.58B | 2.4% | $1.81 | — |
| FY2022ended Dec 31, 2022 | $68.77B | +0.1% | $5.28B | 7.7% | $6.30 | — |
| FY2021ended Dec 31, 2021 | $68.70B | +1.3% | $6.86B | 10.0% | $7.65 | — |
| FY2020ended Dec 31, 2020 | $67.84B | −2.6% | $5.41B | 8.0% | $5.68 | — |
| FY2019ended Dec 31, 2019 | $69.62B | +2.5% | $5.90B | 8.5% | $6.06 | — |
| FY2018ended Dec 31, 2018 | $67.94B | +9.0% | $5.12B | 7.5% | $4.91 | — |
| FY2017ended Dec 31, 2017 | $62.31B | +2.5% | $4.01B | 6.4% | $3.62 | — |
| FY2016ended Dec 31, 2016 | $60.79B | — | $850.00M | 1.4% | $0.67 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $19.15B | $736.00M | $1.09 |
| Q1 FY2026ended Mar 31, 2026 | $19.07B | $1.19B | $1.74 |
| Q4 FY2025ended Dec 31, 2025 | $23.81B | $809.00M | $1.18 |
| Q3 FY2025ended Sep 30, 2025 | $17.36B | $896.00M | $1.22 |
| Q2 FY2025ended Jun 30, 2025 | $17.34B | $729.00M | $1.03 |
| Q1 FY2025ended Mar 31, 2025 | $18.57B | $945.00M | $1.28 |
| Q4 FY2024ended Dec 31, 2024 | $18.67B | $1.27B | $1.75 |
| Q3 FY2024ended Sep 30, 2024 | $18.44B | $1.34B | $1.81 |
Company profile
- Name
- MetLife, Inc.
- Ticker
- MET
- Exchange
- NYSE
- Industry (SEC SIC)
- Life Insurance
- Headquarters
- 200 Park Avenue, New York, NY 10166
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001099219
Recent SEC filings
- Sep 24, 2026
- Aug 17, 2026
- Aug 6, 2026
- Aug 5, 2026
- Jun 29, 2026
- Jun 22, 2026
- May 15, 2026
- May 7, 2026
Frequently asked questions
What is MetLife's stock price?
MetLife (MET) closed at $416.72 on Oct 9, 2026, up 0.75% from the previous close of $413.61.
What is MetLife's market cap?
MetLife's market cap is $265.76B, based on a share price of $416.72 and 637.8M shares outstanding as of Jun 30, 2026.
How much revenue does MetLife make?
MetLife reported revenue of $77.08B for fiscal 2025, up 8.59% from fiscal 2024.
What is MET's P/E ratio?
MetLife's price-to-earnings ratio is 79.7, based on trailing twelve-month diluted EPS of $5.23.
Does MetLife pay a dividend?
MetLife's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from MetLife, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures